BrightSpring Health Services (BTSG) Expected to Post Earnings on Friday

BrightSpring Health Services (NASDAQ:BTSG) is projected to announce its Q2 2026 results before the market opens on Friday, July 31st. Analysts expect the company to post earnings of $0.3963 per share and revenue of $3.6606 billion for the quarter. Parties can find conference call details on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Friday, July 31, 2026 at 8:30 AM ET.

BrightSpring Health Services (NASDAQ:BTSG) last released its earnings results on Friday, May 1st. The company reported $0.39 earnings per share for the quarter, topping analysts’ consensus estimates of $0.29 by $0.10. The company had revenue of $3.61 billion during the quarter, compared to the consensus estimate of $3.39 billion. BrightSpring Health Services had a return on equity of 14.63% and a net margin of 2.27%.BrightSpring Health Services’s quarterly revenue was up 25.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.14 EPS. On average, analysts expect BrightSpring Health Services to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

BrightSpring Health Services Stock Down 4.3%

Shares of BTSG opened at $69.37 on Thursday. The firm has a market cap of $13.69 billion, a P/E ratio of 49.20, a P/E/G ratio of 0.92 and a beta of 1.79. The stock has a 50 day simple moving average of $66.05 and a two-hundred day simple moving average of $51.55. The company has a debt-to-equity ratio of 1.24, a current ratio of 1.74 and a quick ratio of 1.38. BrightSpring Health Services has a 1 year low of $19.01 and a 1 year high of $73.75.

Insider Buying and Selling at BrightSpring Health Services

In other news, insider Jon B. Rousseau sold 130,000 shares of the company’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $58.75, for a total transaction of $7,637,500.00. Following the completion of the transaction, the insider directly owned 1,194,503 shares of the company’s stock, valued at approximately $70,177,051.25. This represents a 9.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Lisa A. Nalley sold 35,000 shares of the stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $58.75, for a total transaction of $2,056,250.00. Following the sale, the insider owned 131,948 shares of the company’s stock, valued at approximately $7,751,945. This represents a 20.96% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 2.80% of the stock is owned by insiders.

Institutional Investors Weigh In On BrightSpring Health Services

Several institutional investors and hedge funds have recently bought and sold shares of the business. EverSource Wealth Advisors LLC purchased a new position in shares of BrightSpring Health Services during the second quarter valued at approximately $43,000. Los Angeles Capital Management LLC purchased a new position in BrightSpring Health Services during the 4th quarter valued at $115,000. Sandia Investment Management LP purchased a new position in BrightSpring Health Services during the 2nd quarter valued at $118,000. Northwestern Mutual Wealth Management Co. raised its holdings in BrightSpring Health Services by 1,371.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,120 shares of the company’s stock worth $192,000 after purchasing an additional 4,772 shares in the last quarter. Finally, PEAK6 LLC purchased a new stake in shares of BrightSpring Health Services in the 4th quarter worth about $206,000.

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. Morgan Stanley lifted their price target on shares of BrightSpring Health Services from $71.00 to $80.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 14th. UBS Group increased their target price on shares of BrightSpring Health Services from $63.00 to $85.00 and gave the company a “buy” rating in a report on Wednesday, July 8th. Bank of America lifted their target price on shares of BrightSpring Health Services from $66.00 to $77.00 and gave the stock a “buy” rating in a research report on Thursday, July 2nd. Stephens boosted their price target on shares of BrightSpring Health Services from $53.00 to $64.00 and gave the stock an “overweight” rating in a research note on Monday, May 4th. Finally, Wells Fargo & Company upped their price target on shares of BrightSpring Health Services from $61.00 to $78.00 and gave the company an “overweight” rating in a research report on Monday, July 13th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $70.12.

About BrightSpring Health Services

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.